Full text
PDF![105](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3a1/497240/a16faae292f7/jnnpsyc00286-0027.png)
![106](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3a1/497240/88df21fb5511/jnnpsyc00286-0028.png)
![107](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3a1/497240/e558a9bf4aaf/jnnpsyc00286-0029.png)
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- ANTON-STEPHENS D. Preliminary observations on the psychiatric uses of chlorpromazine (largactil). J Ment Sci. 1954 Apr;100(419):543–557. doi: 10.1192/bjp.100.419.543. [DOI] [PubMed] [Google Scholar]
- BONAFEDE V. I. Chlorpromazine (thorazine) treatment of disturbed epileptic patients; preliminary report. AMA Arch Neurol Psychiatry. 1955 Aug;74(2):158–162. doi: 10.1001/archneurpsyc.1955.02330140042007. [DOI] [PubMed] [Google Scholar]
- GIACOBINI E., LASSENIUS B. Clorpromazinbehandling; biverkningar och komplikationer. Nord Med. 1954 Dec 2;52(49):1693–1699. [PubMed] [Google Scholar]
- LEHMANN H. E., HANRAHAN G. E. Chlorpromazine; new inhibiting agent for psychomotor excitement and manic states. AMA Arch Neurol Psychiatry. 1954 Feb;71(2):227–237. [PubMed] [Google Scholar]
- LOMAS J., BOARDMAN R. H., MARKOWE M. Complications of chlorpromazine therapy in 800 mental-hospital patients. Lancet. 1955 Jun 4;268(6875):1144–1147. doi: 10.1016/s0140-6736(55)90642-5. [DOI] [PubMed] [Google Scholar]
- MAYR F., LECHNER H. Zur Frage der provokation bei Temporallappen-Epilepsie im EEG. Wien Klin Wochenschr. 1954 Nov 26;66(47):903–906. [PubMed] [Google Scholar]
- SCHLICHTHER W., BRISTOW M. E., SCHULTZ S., HENDERSON A. L. Seizures occurring during intensive chlorpromazine therapy. Can Med Assoc J. 1956 Mar 1;74(5):364–366. [PMC free article] [PubMed] [Google Scholar]
- TURNER M., BERARD E., TURNER N., FRANCO N. Modifications électro-encéphalographiques, électro-dermographiques et électro-myographiques provoquées par la chlorpromazine chez l'homme. Electroencephalogr Clin Neurophysiol. 1956 Feb;8(1):25–34. doi: 10.1016/0013-4694(56)90029-3. [DOI] [PubMed] [Google Scholar]